Table of Content

1 Passive Transdermal Drug Delivery Market Overview
1.1 Passive Transdermal Drug Delivery Product Scope
1.2 Passive Transdermal Drug Delivery Segment by Type
1.2.1 Global Passive Transdermal Drug Delivery Sales by Type (2016 & 2021 & 2027)
1.2.2 Microfluidics
1.2.3 Smart Pill Technology (SPT)
1.3 Passive Transdermal Drug Delivery Segment by Application
1.3.1 Global Passive Transdermal Drug Delivery Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Passive Transdermal Drug Delivery Market Estimates and Forecasts (2016-2027)
1.4.1 Global Passive Transdermal Drug Delivery Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Passive Transdermal Drug Delivery Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Passive Transdermal Drug Delivery Price Trends (2016-2027)

2 Passive Transdermal Drug Delivery Estimates and Forecasts by Region
2.1 Global Passive Transdermal Drug Delivery Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Passive Transdermal Drug Delivery Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2021)
2.2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2016-2021)
2.3 Global Passive Transdermal Drug Delivery Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Passive Transdermal Drug Delivery Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Passive Transdermal Drug Delivery Estimates and Projections (2016-2027)
2.4.2 Europe Passive Transdermal Drug Delivery Estimates and Projections (2016-2027)
2.4.3 China Passive Transdermal Drug Delivery Estimates and Projections (2016-2027)
2.4.4 Japan Passive Transdermal Drug Delivery Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Passive Transdermal Drug Delivery Estimates and Projections (2016-2027)
2.4.6 India Passive Transdermal Drug Delivery Estimates and Projections (2016-2027)

3 Global Passive Transdermal Drug Delivery Competition Landscape by Players
3.1 Global Top Passive Transdermal Drug Delivery Players by Sales (2016-2021)
3.2 Global Top Passive Transdermal Drug Delivery Players by Revenue (2016-2021)
3.3 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Passive Transdermal Drug Delivery as of 2020)
3.4 Global Passive Transdermal Drug Delivery Average Price by Company (2016-2021)
3.5 Manufacturers Passive Transdermal Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Passive Transdermal Drug Delivery Market Size by Type
4.1 Global Passive Transdermal Drug Delivery Historic Market Review by Type (2016-2021)
4.1.1 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
4.1.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2016-2021)
4.1.3 Global Passive Transdermal Drug Delivery Price by Type (2016-2021)
4.2 Global Passive Transdermal Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Passive Transdermal Drug Delivery Sales Forecast by Type (2022-2027)
4.2.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2022-2027)
4.2.3 Global Passive Transdermal Drug Delivery Price Forecast by Type (2022-2027)

5 Global Passive Transdermal Drug Delivery Market Size by Application
5.1 Global Passive Transdermal Drug Delivery Historic Market Review by Application (2016-2021)
5.1.1 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
5.1.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2016-2021)
5.1.3 Global Passive Transdermal Drug Delivery Price by Application (2016-2021)
5.2 Global Passive Transdermal Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Passive Transdermal Drug Delivery Sales Forecast by Application (2022-2027)
5.2.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Application (2022-2027)
5.2.3 Global Passive Transdermal Drug Delivery Price Forecast by Application (2022-2027)

6 North America Passive Transdermal Drug Delivery Market Facts & Figures
6.1 North America Passive Transdermal Drug Delivery Sales by Company
6.1.1 North America Passive Transdermal Drug Delivery Sales by Company (2016-2021)
6.1.2 North America Passive Transdermal Drug Delivery Revenue by Company (2016-2021)
6.2 North America Passive Transdermal Drug Delivery Sales Breakdown by Type
6.2.1 North America Passive Transdermal Drug Delivery Sales Breakdown by Type (2016-2021)
6.2.2 North America Passive Transdermal Drug Delivery Sales Breakdown by Type (2022-2027)
6.3 North America Passive Transdermal Drug Delivery Sales Breakdown by Application
6.3.1 North America Passive Transdermal Drug Delivery Sales Breakdown by Application (2016-2021)
6.3.2 North America Passive Transdermal Drug Delivery Sales Breakdown by Application (2022-2027)

7 Europe Passive Transdermal Drug Delivery Market Facts & Figures
7.1 Europe Passive Transdermal Drug Delivery Sales by Company
7.1.1 Europe Passive Transdermal Drug Delivery Sales by Company (2016-2021)
7.1.2 Europe Passive Transdermal Drug Delivery Revenue by Company (2016-2021)
7.2 Europe Passive Transdermal Drug Delivery Sales Breakdown by Type
7.2.1 Europe Passive Transdermal Drug Delivery Sales Breakdown by Type (2016-2021)
7.2.2 Europe Passive Transdermal Drug Delivery Sales Breakdown by Type (2022-2027)
7.3 Europe Passive Transdermal Drug Delivery Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Passive Transdermal Drug Delivery Market Facts & Figures
8.1 China Passive Transdermal Drug Delivery Sales by Company
8.1.1 China Passive Transdermal Drug Delivery Sales by Company (2016-2021)
8.1.2 China Passive Transdermal Drug Delivery Revenue by Company (2016-2021)
8.2 China Passive Transdermal Drug Delivery Sales Breakdown by Type
8.2.1 China Passive Transdermal Drug Delivery Sales Breakdown by Type (2016-2021)
8.2.2 China Passive Transdermal Drug Delivery Sales Breakdown by Type (2022-2027)
8.3 China Passive Transdermal Drug Delivery Sales Breakdown by Application
8.3.1 China 154 Sales Breakdown by Application (2016-2021)
8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Passive Transdermal Drug Delivery Market Facts & Figures
9.1 Japan Passive Transdermal Drug Delivery Sales by Company
9.1.1 Japan Passive Transdermal Drug Delivery Sales by Company (2016-2021)
9.1.2 Japan Passive Transdermal Drug Delivery Revenue by Company (2016-2021)
9.2 Japan Passive Transdermal Drug Delivery Sales Breakdown by Type
9.2.1 Japan Passive Transdermal Drug Delivery Sales Breakdown by Type (2016-2021)
9.2.2 Japan Passive Transdermal Drug Delivery Sales Breakdown by Type (2022-2027)
9.3 Japan Passive Transdermal Drug Delivery Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Passive Transdermal Drug Delivery Market Facts & Figures
10.1 Southeast Asia Passive Transdermal Drug Delivery Sales by Company
10.1.1 Southeast Asia Passive Transdermal Drug Delivery Sales by Company (2016-2021)
10.1.2 Southeast Asia Passive Transdermal Drug Delivery Revenue by Company (2016-2021)
10.2 Southeast Asia Passive Transdermal Drug Delivery Sales Breakdown by Type
10.2.1 Southeast Asia Passive Transdermal Drug Delivery Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Passive Transdermal Drug Delivery Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Passive Transdermal Drug Delivery Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Passive Transdermal Drug Delivery Market Facts & Figures
11.1 India Passive Transdermal Drug Delivery Sales by Company
11.1.1 India Passive Transdermal Drug Delivery Sales by Company (2016-2021)
11.1.2 India Passive Transdermal Drug Delivery Revenue by Company (2016-2021)
11.2 India Passive Transdermal Drug Delivery Sales Breakdown by Type
11.2.1 India Passive Transdermal Drug Delivery Sales Breakdown by Type (2016-2021)
11.2.2 India Passive Transdermal Drug Delivery Sales Breakdown by Type (2022-2027)
11.3 India Passive Transdermal Drug Delivery Sales Breakdown by Application
11.3.1 India Passive Transdermal Drug Delivery Sales Breakdown by Application (2016-2021)
11.3.2 India Passive Transdermal Drug Delivery Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Passive Transdermal Drug Delivery Business
12.1 3M
12.1.1 3M Corporation Information
12.1.2 3M Business Overview
12.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.1.4 3M Passive Transdermal Drug Delivery Products Offered
12.1.5 3M Recent Development
12.2 Actavis, Inc.
12.2.1 Actavis, Inc. Corporation Information
12.2.2 Actavis, Inc. Business Overview
12.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Products Offered
12.2.5 Actavis, Inc. Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Corporation Information
12.3.2 Bayer AG Business Overview
12.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer AG Passive Transdermal Drug Delivery Products Offered
12.3.5 Bayer AG Recent Development
12.4 Boehringer Ingelheim GmbH
12.4.1 Boehringer Ingelheim GmbH Corporation Information
12.4.2 Boehringer Ingelheim GmbH Business Overview
12.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Products Offered
12.4.5 Boehringer Ingelheim GmbH Recent Development
12.5 Corium International, Inc.
12.5.1 Corium International, Inc. Corporation Information
12.5.2 Corium International, Inc. Business Overview
12.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Products Offered
12.5.5 Corium International, Inc. Recent Development
12.6 Echo Therapeutics, Inc.
12.6.1 Echo Therapeutics, Inc. Corporation Information
12.6.2 Echo Therapeutics, Inc. Business Overview
12.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Products Offered
12.6.5 Echo Therapeutics, Inc. Recent Development
12.7 GlaxoSmithKline plc
12.7.1 GlaxoSmithKline plc Corporation Information
12.7.2 GlaxoSmithKline plc Business Overview
12.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Products Offered
12.7.5 GlaxoSmithKline plc Recent Development
12.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
12.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
12.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
12.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Products Offered
12.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
12.9 Mylan N.V.
12.9.1 Mylan N.V. Corporation Information
12.9.2 Mylan N.V. Business Overview
12.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan N.V. Passive Transdermal Drug Delivery Products Offered
12.9.5 Mylan N.V. Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Business Overview
12.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis AG Passive Transdermal Drug Delivery Products Offered
12.10.5 Novartis AG Recent Development
12.11 Noven Pharmaceuticals, Inc.
12.11.1 Noven Pharmaceuticals, Inc. Corporation Information
12.11.2 Noven Pharmaceuticals, Inc. Business Overview
12.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Products Offered
12.11.5 Noven Pharmaceuticals, Inc. Recent Development
12.12 Transdermal Corp.
12.12.1 Transdermal Corp. Corporation Information
12.12.2 Transdermal Corp. Business Overview
12.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Products Offered
12.12.5 Transdermal Corp. Recent Development

13 Passive Transdermal Drug Delivery Manufacturing Cost Analysis
13.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
13.4 Passive Transdermal Drug Delivery Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Passive Transdermal Drug Delivery Distributors List
14.3 Passive Transdermal Drug Delivery Customers

15 Market Dynamics
15.1 Passive Transdermal Drug Delivery Market Trends
15.2 Passive Transdermal Drug Delivery Drivers
15.3 Passive Transdermal Drug Delivery Market Challenges
15.4 Passive Transdermal Drug Delivery Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Passive Transdermal Drug Delivery Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Passive Transdermal Drug Delivery Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Passive Transdermal Drug Delivery Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Passive Transdermal Drug Delivery Sales (K Units) by Region (2016-2021)
Table 5. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2021)
Table 6. Global Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Passive Transdermal Drug Delivery Revenue Share by Region (2016-2021)
Table 8. Global Passive Transdermal Drug Delivery Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Passive Transdermal Drug Delivery Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Passive Transdermal Drug Delivery Revenue Share Forecast by Region (2022-2027)
Table 12. Global Passive Transdermal Drug Delivery Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Passive Transdermal Drug Delivery Sales Share by Company (2016-2021)
Table 14. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Passive Transdermal Drug Delivery Revenue Share by Company (2016-2021)
Table 16. Global Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Passive Transdermal Drug Delivery as of 2020)
Table 17. Global Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Passive Transdermal Drug Delivery Manufacturing Sites and Area Served
Table 19. Manufacturers Passive Transdermal Drug Delivery Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Passive Transdermal Drug Delivery Sales (K Units) by Type (2016-2021)
Table 22. Global Passive Transdermal Drug Delivery Sales Share by Type (2016-2021)
Table 23. Global Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2016-2021)
Table 25. Global Passive Transdermal Drug Delivery Sales Share by Type (2022-2027)
Table 26. Global Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Passive Transdermal Drug Delivery Revenue Share by Type (2022-2027)
Table 28. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2022-2027)
Table 29. Global Passive Transdermal Drug Delivery Sales (K Units) by Application (2016-2021)
Table 30. Global Passive Transdermal Drug Delivery Sales Share by Application (2016-2021)
Table 31. Global Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Application (2016-2021)
Table 33. Global Passive Transdermal Drug Delivery Sales (K Units) by Application (2022-2027)
Table 34. Global Passive Transdermal Drug Delivery Sales Share by Application (2022-2027)
Table 35. Global Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Passive Transdermal Drug Delivery Revenue Share by Application (2022-2027)
Table 37. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Application (2022-2027)
Table 38. North America Passive Transdermal Drug Delivery Sales (K Units) by Company (2016-2021)
Table 39. North America Passive Transdermal Drug Delivery Sales Market Share by Company (2016-2021)
Table 40. North America Passive Transdermal Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Passive Transdermal Drug Delivery Revenue Market Share by Company (2016-2021)
Table 42. North America Passive Transdermal Drug Delivery Sales by Type (2016-2021) & (K Units)
Table 43. North America Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
Table 44. North America Passive Transdermal Drug Delivery Sales by Type (2022-2027) & (K Units)
Table 45. North America Passive Transdermal Drug Delivery Sales Market Share by Type (2022-2027)
Table 46. North America Passive Transdermal Drug Delivery Sales by Application (2016-2021) & (K Units)
Table 47. North America Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
Table 48. North America Passive Transdermal Drug Delivery Sales by Application (2022-2027) & (K Units)
Table 49. North America Passive Transdermal Drug Delivery Sales Market Share by Application (2022-2027)
Table 50. Europe Passive Transdermal Drug Delivery Sales (K Units) by Company (2016-2021)
Table 51. Europe Passive Transdermal Drug Delivery Sales Market Share by Company (2016-2021)
Table 52. Europe Passive Transdermal Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Passive Transdermal Drug Delivery Revenue Market Share by Company (2016-2021)
Table 54. Europe Passive Transdermal Drug Delivery Sales by Type (2016-2021) & (K Units)
Table 55. Europe Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
Table 56. Europe Passive Transdermal Drug Delivery Sales by Type (2022-2027) & (K Units)
Table 57. Europe Passive Transdermal Drug Delivery Sales Market Share by Type (2022-2027)
Table 58. Europe Passive Transdermal Drug Delivery Sales by Application (2016-2021) & (K Units)
Table 59. Europe Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
Table 60. Europe Passive Transdermal Drug Delivery Sales by Application (2022-2027) & (K Units)
Table 61. Europe Passive Transdermal Drug Delivery Sales Market Share by Application (2022-2027)
Table 62. China Passive Transdermal Drug Delivery Sales (K Units) by Company (2016-2021)
Table 63. China Passive Transdermal Drug Delivery Sales Market Share by Company (2016-2021)
Table 64. China Passive Transdermal Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Passive Transdermal Drug Delivery Revenue Market Share by Company (2016-2021)
Table 66. China Passive Transdermal Drug Delivery Sales by Type (2016-2021) & (K Units)
Table 67. China Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
Table 68. China Passive Transdermal Drug Delivery Sales by Type (2022-2027) & (K Units)
Table 69. China Passive Transdermal Drug Delivery Sales Market Share by Type (2022-2027)
Table 70. China Passive Transdermal Drug Delivery Sales by Application (2016-2021) & (K Units)
Table 71. China Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
Table 72. China Passive Transdermal Drug Delivery Sales by Application (2022-2027) & (K Units)
Table 73. China Passive Transdermal Drug Delivery Sales Market Share by Application (2022-2027)
Table 74. Japan Passive Transdermal Drug Delivery Sales (K Units) by Company (2016-2021)
Table 75. Japan Passive Transdermal Drug Delivery Sales Market Share by Company (2016-2021)
Table 76. Japan Passive Transdermal Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Passive Transdermal Drug Delivery Revenue Market Share by Company (2016-2021)
Table 78. Japan Passive Transdermal Drug Delivery Sales by Type (2016-2021) & (K Units)
Table 79. Japan Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
Table 80. Japan Passive Transdermal Drug Delivery Sales by Type (2022-2027) & (K Units)
Table 81. Japan Passive Transdermal Drug Delivery Sales Market Share by Type (2022-2027)
Table 82. Japan Passive Transdermal Drug Delivery Sales by Application (2016-2021) & (K Units)
Table 83. Japan Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
Table 84. Japan Passive Transdermal Drug Delivery Sales by Application (2022-2027) & (K Units)
Table 85. Japan Passive Transdermal Drug Delivery Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Passive Transdermal Drug Delivery Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Passive Transdermal Drug Delivery Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Passive Transdermal Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Passive Transdermal Drug Delivery Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Passive Transdermal Drug Delivery Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Passive Transdermal Drug Delivery Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Passive Transdermal Drug Delivery Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Passive Transdermal Drug Delivery Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Passive Transdermal Drug Delivery Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Passive Transdermal Drug Delivery Sales Market Share by Application (2022-2027)
Table 98. India Passive Transdermal Drug Delivery Sales (K Units) by Company (2016-2021)
Table 99. India Passive Transdermal Drug Delivery Sales Market Share by Company (2016-2021)
Table 100. India Passive Transdermal Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Passive Transdermal Drug Delivery Revenue Market Share by Company (2016-2021)
Table 102. India Passive Transdermal Drug Delivery Sales by Type (2016-2021) & (K Units)
Table 103. India Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
Table 104. India Passive Transdermal Drug Delivery Sales by Type (2022-2027) & (K Units)
Table 105. India Passive Transdermal Drug Delivery Sales Market Share by Type (2022-2027)
Table 106. India Passive Transdermal Drug Delivery Sales by Application (2016-2021) & (K Units)
Table 107. India Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
Table 108. India Passive Transdermal Drug Delivery Sales by Application (2022-2027) & (K Units)
Table 109. India Passive Transdermal Drug Delivery Sales Market Share by Application (2022-2027)
Table 110. 3M Corporation Information
Table 111. 3M Description and Business Overview
Table 112. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. 3M Passive Transdermal Drug Delivery Product
Table 114. 3M Recent Development
Table 115. Actavis, Inc. Corporation Information
Table 116. Actavis, Inc. Description and Business Overview
Table 117. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Actavis, Inc. Passive Transdermal Drug Delivery Product
Table 119. Actavis, Inc. Recent Development
Table 120. Bayer AG Corporation Information
Table 121. Bayer AG Description and Business Overview
Table 122. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Bayer AG Passive Transdermal Drug Delivery Product
Table 124. Bayer AG Recent Development
Table 125. Boehringer Ingelheim GmbH Corporation Information
Table 126. Boehringer Ingelheim GmbH Description and Business Overview
Table 127. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product
Table 129. Boehringer Ingelheim GmbH Recent Development
Table 130. Corium International, Inc. Corporation Information
Table 131. Corium International, Inc. Description and Business Overview
Table 132. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Corium International, Inc. Passive Transdermal Drug Delivery Product
Table 134. Corium International, Inc. Recent Development
Table 135. Echo Therapeutics, Inc. Corporation Information
Table 136. Echo Therapeutics, Inc. Description and Business Overview
Table 137. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product
Table 139. Echo Therapeutics, Inc. Recent Development
Table 140. GlaxoSmithKline plc Corporation Information
Table 141. GlaxoSmithKline plc Description and Business Overview
Table 142. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product
Table 144. GlaxoSmithKline plc Recent Development
Table 145. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 146. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 148. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product
Table 149. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
Table 150. Mylan N.V. Corporation Information
Table 151. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Mylan N.V. Description and Business Overview
Table 153. Mylan N.V. Passive Transdermal Drug Delivery Product
Table 154. Mylan N.V. Recent Development
Table 155. Novartis AG Corporation Information
Table 156. Novartis AG Description and Business Overview
Table 157. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Novartis AG Passive Transdermal Drug Delivery Product
Table 159. Novartis AG Recent Development
Table 160. Noven Pharmaceuticals, Inc. Corporation Information
Table 161. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 162. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product
Table 164. Noven Pharmaceuticals, Inc. Recent Development
Table 165. Transdermal Corp. Corporation Information
Table 166. Transdermal Corp. Description and Business Overview
Table 167. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Transdermal Corp. Passive Transdermal Drug Delivery Product
Table 169. Transdermal Corp. Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Passive Transdermal Drug Delivery Distributors List
Table 173. Passive Transdermal Drug Delivery Customers List
Table 174. Passive Transdermal Drug Delivery Market Trends
Table 175. Passive Transdermal Drug Delivery Market Drivers
Table 176. Passive Transdermal Drug Delivery Market Challenges
Table 177. Passive Transdermal Drug Delivery Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Passive Transdermal Drug Delivery Product Picture
Figure 2. Global Passive Transdermal Drug Delivery Sales Market Share by Type in 2021 & 2027
Figure 3. Microfluidics Product Picture
Figure 4. Smart Pill Technology (SPT) Product Picture
Figure 5. Global Passive Transdermal Drug Delivery Sales Market Share by Application in 2021 & 2027
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Others Examples
Figure 9. Global Passive Transdermal Drug Delivery Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Passive Transdermal Drug Delivery Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Passive Transdermal Drug Delivery Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Passive Transdermal Drug Delivery Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Passive Transdermal Drug Delivery Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Passive Transdermal Drug Delivery Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Passive Transdermal Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Passive Transdermal Drug Delivery Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Passive Transdermal Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Passive Transdermal Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Passive Transdermal Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Passive Transdermal Drug Delivery Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Passive Transdermal Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Passive Transdermal Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Passive Transdermal Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Passive Transdermal Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Passive Transdermal Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Passive Transdermal Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Passive Transdermal Drug Delivery Players Market Share by Revenue in Passive Transdermal Drug Delivery: 2016 & 2020
Figure 28. Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Passive Transdermal Drug Delivery Revenue Share by Type (2016-2021)
Figure 30. Global Passive Transdermal Drug Delivery Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Passive Transdermal Drug Delivery Revenue Share by Application (2016-2021)
Figure 32. Global Passive Transdermal Drug Delivery Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Passive Transdermal Drug Delivery Sales Market Share by Type in 2020
Figure 34. North America Passive Transdermal Drug Delivery Sales Market Share by Application in 2020
Figure 35. Europe Passive Transdermal Drug Delivery Sales Market Share by Type in 2020
Figure 36. Europe Passive Transdermal Drug Delivery Sales Market Share by Application in 2020
Figure 37. China Passive Transdermal Drug Delivery Sales Market Share by Type in 2020
Figure 38. China Passive Transdermal Drug Delivery Sales Market Share by Application in 2020
Figure 39. Japan Passive Transdermal Drug Delivery Sales Market Share by Type in 2020
Figure 40. Japan Passive Transdermal Drug Delivery Sales Market Share by Application in 2020
Figure 41. Southeast Asia Passive Transdermal Drug Delivery Sales Market Share by Type in 2020
Figure 42. Southeast Asia Passive Transdermal Drug Delivery Sales Market Share by Application in 2020
Figure 43. India Passive Transdermal Drug Delivery Sales Market Share by Type in 2020
Figure 44. India Passive Transdermal Drug Delivery Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Figure 47. Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure 48. Passive Transdermal Drug Delivery Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed